Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
europe blog main
3
×
fda
life sciences
national blog main
boston blog main
boston top stories
cancer
clinical trials
eli lilly
national
national top stories
new york blog main
san francisco blog main
abbvie
accent therapeutics
aducanumab
allergan
alzheimer's disease
amblyotech
amgen
asklepios biopharmaceutical
bioeurope
biogen
biohaven
biomarin pharmaceutical
black diamond therapeutics
bladder cancer
blueprint medicines
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cancer drugs
cara therapeutics
cgpr
deciphera pharmaceuticals
deerfield management
detroit blog main
detroit top stories
What
medicines
3
×
new
3
×
fda
ipo
activity
adults
allergan
approvals
approved
bio
biogen
biotech
black
cancer
clamped
class
clinic
companies
covid
delays
developing
diamond
drug
economic
eluded
fast
hopes
including
isn’t
lead
leading
lines
lot
migraine
molecular
monday
nears
nod
oric’s
phase
Language
unset
Current search:
medicines
×
new
×
" europe blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
